Provided by Tiger Trade Technology Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

11.12
+0.34003.15%
Volume:817.44K
Turnover:9.07M
Market Cap:3.77B
PE:116.58
High:11.14
Open:11.01
Low:11.00
Close:10.78
52wk High:13.11
52wk Low:6.28
Shares:339.00M
Float Shares:272.00M
Volume Ratio:3.11
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0954
EPS(LYR):-0.0211
ROE:7.36%
ROA:2.71%
PB:7.73
PE(LYR):-527.01

Loading ...

Telix Pharmaceuticals Price Target Maintained with a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 02

Telix Pharmaceuticals Completes Patient Enrollment in Phase Three Study of PSMA-PET Imaging Agents for Prostate Cancer Imaging

MT Newswires Live
·
Sep 02

Telix Wraps Phase 3 BiPASS Enrollment, Secures FDA NDA Pathway for Expanded PSMA-PET Use

TIPRANKS
·
Sep 02

ASX Growth Companies With High Insider Ownership You Should Know

Simply Wall St.
·
Sep 02

Press Release: Telix Appoints David Gill as Chair

Dow Jones
·
Sep 01

Cochlear Stock And Two ASX Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Aug 30

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.
·
Aug 28

Cash Flow Stocks Retail Investors May Be Missing In Australia

Simply Wall St.
·
Aug 27

Telix Pharmaceuticals Stock Leads 3 ASX Picks Trading Below Cash Flow Value

Simply Wall St.
·
Aug 25

3 Fast Growing Australian Stocks With High Insider Ownership Worth Watching

Simply Wall St.
·
Aug 25

ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value

Simply Wall St.
·
Aug 25

Ord Minnett Reaffirms Their Buy Rating on Telix Pharmaceuticals (TLPPF)

TIPRANKS
·
Aug 24

WiseTech Global Stock And 2 Australian Shares Trading Below Cash Flow Value

Simply Wall St.
·
Aug 24

Mesoblast Stock Leads 3 Fast Growing ASX Picks With Strong Insider Ownership

Simply Wall St.
·
Aug 23

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Takeda Pharmaceutical Co (OtherTKPHF)

TIPRANKS
·
Aug 23

Cash Flow Stocks Worth A Closer Look As Bond Yields Stay High

Simply Wall St.
·
Aug 23

Jarden Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)

TIPRANKS
·
Aug 22

Mesoblast Stock Leads 3 High Growth Insider Owned ASX Shares To Watch

Simply Wall St.
·
Aug 21

Telix Pharmaceuticals Price Target Maintained with a $22.00/Share by Wedbush

Dow Jones
·
Aug 21

Telix Pharmaceuticals: Buy Rating Reiterated with Unchanged $31 Target Ahead of Key Pixclara Regulatory Catalyst

TIPRANKS
·
Aug 20